BiotechTubeBiotechTube
Home/Cassava Sciences/David R. Gwynn, J.D.
DR

David R. Gwynn, J.D.

Senior Vice President, General Counsel, and Corporate Secretary

Cassava Sciences

Therapeutic Areas

Alzheimer's DiseaseNeurodegenerative Diseases

Cassava Sciences Pipeline

DrugIndicationPhase
Simufilam (PTI-125)Alzheimer's DiseasePhase 3
SavaDxAlzheimer's Disease (Diagnostic)Pre-clinical

Leadership Team at Cassava Sciences

RB
Remi Barbier
President, Chief Executive Officer, and Chairman of the Board
EJ
Eric J. Schoen
Chief Financial Officer
JW
James W. Kupiec, M.D.
Chief Medical Officer
LA
Lindsay A. Burns, Ph.D.
Senior Vice President of Neuroscience
SR
Sanford Robertson
Director
RB
Richard Barry
Director
PJ
Patrick J. McEnany
Director
View full Cassava Sciences profile